HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Maureen Trudeau Selected Research
Maureen Trudeau Research Topics
Disease
55
Breast Neoplasms (Breast Cancer)
02/2022 - 03/2003
34
Neoplasms (Cancer)
01/2022 - 06/2003
4
Pain (Aches)
01/2022 - 11/2004
3
Fatigue
01/2022 - 03/2016
3
Disease Progression
10/2019 - 08/2004
3
Triple Negative Breast Neoplasms
11/2009 - 08/2007
3
Neoplasm Metastasis (Metastasis)
10/2006 - 01/2004
2
Nausea
12/2020 - 09/2007
2
Inflammatory Breast Neoplasms
06/2009 - 03/2008
1
Central Nervous System Diseases (CNS Diseases)
10/2021
1
Brain Neoplasms (Brain Tumor)
10/2021
1
Glioma (Gliomas)
01/2019
1
Cognitive Dysfunction
01/2019
1
Sleep Deprivation
03/2016
1
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
08/2014
1
Mouth Neoplasms (Oral Cancer)
02/2011
1
Cardiovascular Diseases (Cardiovascular Disease)
04/2008
1
Vomiting
09/2007
1
Hypesthesia (Numbness)
11/2004
1
Circulating Neoplastic Cells
08/2004
Drug/Important Bio-Agent (IBA)
7
Anthracyclines
IBA
06/2009 - 09/2005
6
Trastuzumab (Herceptin)
FDA Link
02/2022 - 10/2008
6
Pharmaceutical Preparations
IBA
01/2022 - 02/2011
6
Hormones (Hormone)
IBA
12/2020 - 06/2003
6
Estrogen Receptors
IBA
07/2017 - 08/2007
6
Tamoxifen
FDA Link
Generic
04/2008 - 03/2003
5
Progesterone Receptors (Progesterone Receptor)
IBA
07/2013 - 08/2007
4
human ERBB2 protein
IBA
10/2019 - 03/2008
4
Biomarkers (Surrogate Marker)
IBA
03/2016 - 03/2008
4
taxane
IBA
07/2015 - 09/2005
3
exemestane (Aromasin)
FDA Link
12/2020 - 08/2007
3
Anastrozole (Arimidex)
FDA Link
Generic
06/2012 - 06/2003
3
Diphosphonates (Bisphosphonates)
IBA
10/2006 - 01/2004
2
pertuzumab
IBA
02/2022 - 01/2022
2
Doxorubicin (Adriamycin)
FDA Link
Generic
07/2015 - 08/2014
2
Cyclophosphamide (Cytoxan)
FDA Link
Generic
07/2015 - 08/2014
2
ErbB Receptors (EGF Receptor)
IBA
11/2009 - 06/2009
2
Lapatinib (GW572016)
FDA Link
06/2009 - 03/2008
2
Letrozole (Femara)
FDA Link
Generic
04/2008 - 06/2003
2
Aromatase Inhibitors
IBA
04/2008 - 06/2003
2
Pamidronate (Aredia)
FDA Link
Generic
10/2006 - 01/2004
2
Clodronic Acid (Clodronate)
IBA
10/2006 - 01/2004
1
Monoclonal Antibodies
IBA
10/2021
1
Androgen Receptors (Androgen Receptor)
IBA
12/2020
1
enzalutamide
IBA
12/2020
1
Epidermal Growth Factor (EGF)
IBA
03/2020
1
Temozolomide (Temodar)
FDA Link
Generic
01/2019
1
liposomal doxorubicin (Doxil)
FDA Link
01/2019
1
Melatonin
IBA
03/2016
1
Fluorouracil (Carac)
FDA Link
Generic
07/2015
1
P-2 (P 2)
IBA
07/2015
1
Docetaxel (Taxotere)
FDA Link
07/2015
1
Epirubicin (Ellence)
FDA Link
Generic
07/2015
1
Paclitaxel (Taxol)
FDA Link
Generic
07/2015
1
RNA (Ribonucleic Acid)
IBA
05/2015
1
Solutions
IBA
12/2014
1
Rituximab (Mabthera)
FDA Link
08/2014
1
Vincristine (Oncovin)
FDA Link
Generic
08/2014
1
Prednisone (Sone)
FDA Link
Generic
08/2014
1
Fulvestrant (Faslodex)
FDA Link
06/2012
1
CM 55
IBA
11/2009
1
Keratin-5 (Keratin 5)
IBA
11/2009
1
Cytotoxins (Cytolysins)
IBA
09/2009
1
Phosphotransferases (Kinase)
IBA
06/2009
1
Tyrosine (L-Tyrosine)
FDA Link
06/2009
1
Enzymes
IBA
12/2008
1
Vitamin B Complex (B Vitamins)
IBA
12/2008
1
Folic Acid (Vitamin M)
FDA Link
Generic
12/2008
1
Carrier Proteins (Binding Protein)
IBA
12/2008
1
Gemcitabine
FDA Link
04/2008
1
Antiemetics
IBA
09/2007
1
Vinorelbine (Navelbine)
FDA Link
Generic
06/2007
1
Capecitabine (Xeloda)
FDA Link
06/2007
1
Zoledronic Acid (Zometa)
FDA Link
10/2006
1
collagen type I trimeric cross-linked peptide
IBA
10/2006
1
Estrogens (Estrogen)
FDA Link
02/2005
1
Indicators and Reagents (Reagents)
IBA
08/2004
1
Biological Products
IBA
08/2004
Therapy/Procedure
23
Therapeutics
01/2022 - 06/2003
19
Drug Therapy (Chemotherapy)
02/2022 - 09/2005
15
Neoadjuvant Therapy
02/2022 - 11/2003
9
Adjuvant Chemotherapy
10/2020 - 11/2005
4
Segmental Mastectomy (Lumpectomy)
04/2020 - 03/2003
3
Radiotherapy
04/2020 - 02/2005
3
Mastectomy (Mammectomy)
02/2013 - 02/2005
2
Aftercare (After-Treatment)
11/2004 - 03/2003
1
Adjuvant Radiotherapy
04/2020
1
Polypharmacy
01/2019
1
Combination Drug Therapy (Combination Chemotherapy)
11/2005
1
Complementary Therapies (Alternative Medicine)
11/2004
1
Contraindications
03/2003